Bank Of Montreal Cytosorbents Corp Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.76 - $3.22 $39,642 - $72,527	-22,524 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.88 - $4.23 $64,869 - $95,276	22,524 New	22,524 $70,000
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $477,762 - $956,704	-117,966 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $825,762 - $1.15 Million	117,966 New	117,966 $1.01 Million

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $42.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.